CNOT6L expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.98829999997763E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.099100E-03 |
Normal-vs-Stage2 |
1.127790E-01 |
Normal-vs-Stage3 |
9.22489995502929E-09 |
Normal-vs-Stage4 |
6.04310002039199E-09 |
Stage1-vs-Stage2 |
7.958000E-01 |
Stage1-vs-Stage3 |
1.591890E-04 |
Stage1-vs-Stage4 |
5.89439999999497E-05 |
Stage2-vs-Stage3 |
9.999600E-02 |
Stage2-vs-Stage4 |
5.026100E-02 |
Stage3-vs-Stage4 |
5.311800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.59147999999609E-05 |
Normal-vs-AfricanAmerican |
6.256299999996E-05 |
Normal-vs-Asian |
6.525200E-01 |
Caucasian-vs-AfricanAmerican |
1.233850E-01 |
Caucasian-vs-Asian |
5.407800E-01 |
AfricanAmerican-vs-Asian |
2.447600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.5486000000029E-05 |
Normal-vs-Female |
1.65988999999422E-05 |
Male-vs-Female |
5.208800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.414400E-02 |
Normal-vs-Age(41-60Yrs) |
1.449750E-02 |
Normal-vs-Age(61-80Yrs) |
1.88330000483461E-08 |
Normal-vs-Age(81-100Yrs) |
7.53090000027434E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.552800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.223600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.079380E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.882100E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.317200E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.291050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.083800E-01 |
Normal-vs-Grade 2 |
3.774200E-02 |
Normal-vs-Grade 3 |
2.67020000555007E-08 |
Normal-vs-Grade 4 |
3.68669983430436E-10 |
Grade 1-vs-Grade 2 |
1.369420E-01 |
Grade 1-vs-Grade 3 |
1.016100E-03 |
Grade 1-vs-Grade 4 |
5.7219999999969E-05 |
Grade 2-vs-Grade 3 |
5.160300E-04 |
Grade 2-vs-Grade 4 |
1.19730000003315E-06 |
Grade 3-vs-Grade 4 |
2.778100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.888390E-01 |
Normal-vs-ccB subtype |
2.18709999999511E-06 |
ccA subtype-vs-ccB subtype |
8.420600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.80160000000341E-05 |
Normal-vs-N1 |
2.922500E-02 |
N0-vs-N1 |
4.178600E-01 |
|
|